Drug repurposing has tremendous potential to help address the thousands of rare and common diseases that remain without effective treatments. However, many researchers may be embarking translational studies and drug product development for the very first time. The REMEDi4ALL platform is supported by the EC to partner with academics, nascent biotechs, and patient groups to bring comprehensive expertise and resources to facilitate development of new therapeutic opportunities for existing drugs—whether approved or investigational-stage but "shelved" for commercial reasons—from laboratory/clinical research through to market entry and patient access.
This webinar is organised by the BioMedical SIG. Join the BioMedical SIG to stay informed.
Great networking, new knowledge and inspiration!
Jonas Rimbäck
University of Gothenburg, Sweden
Good opportunity to discuss common issues with fellow professionals and to get updates about the community.
Giuseppe Visimberga
Leiden University, Netherlands
Always simply inspiring! That is ASTP.
Filip Auinger
Palacký University Olomouc, Czech Republic
The course exceeded my expectations. We exchanged experiences and learned different options of approaches to existing problems.
Patricia Lima
Instituto Superior Technico, Portugal
I am happy to be able to share my own experiences with other colleagues via various courses, and I enjoy every moment I can spend in this network. Proud to be part of the ASTP community!
Paul van Dun
KU Leuven, Belgium
Join our newsletter and get the latest news